Targeting a molecule involved in the activation and movement of white blood cells could prevent the progression of multiple sclerosis (MS), University of Adelaide researchers have found. The scientists focused on a molecule known as PI3Kgamma (PI3K) and have shown More…
Comment on this article
You must be logged in to post a comment.